Welcome to C2I, JA Bio Inc.!

The C2I team is excited to announce our new resident company, JA Bio Inc.

JA Bio Inc. is a startup bio-technology company focused on anti-cancer cell immune therapeutics discovery and development.

Their R&D consists of:

→ Tumor immunotherapy industry biomedical research.

→ Anti-cancer immune cells, protein, DNA, and growth factors of drug and technology research and development.

→ Related equipment, reagents process research, and development for licensing and clinic retail.

Their Business activities include:

→ Medical technology development and technical services.

→Technology support & technical consultation.

→ Medical equipment import & export agents allowed by legal licensing distribution.

Learn more about JA Bio Inc. here.